Success Metrics

Clinical Success Rate
91.7%

Based on 77 completed trials

Completion Rate
92%(77/84)
Active Trials
3(3%)
Results Posted
23%(18 trials)
Terminated
7(6%)

Phase Distribution

Ph phase_2
22
20%
Ph phase_4
12
11%
Ph phase_3
32
29%
Ph phase_1
13
12%
Ph not_applicable
30
27%

Phase Distribution

13

Early Stage

22

Mid Stage

44

Late Stage

Phase Distribution109 total trials
Phase 1Safety & dosage
13(11.9%)
Phase 2Efficacy & side effects
22(20.2%)
Phase 3Large-scale testing
32(29.4%)
Phase 4Post-market surveillance
12(11.0%)
N/ANon-phased studies
30(27.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

77 of 88 finished

Non-Completion Rate

12.5%

11 ended early

Currently Active

3

trials recruiting

Total Trials

110

all time

Status Distribution
Active(4)
Completed(77)
Terminated(11)
Other(18)

Detailed Status

Completed77
unknown18
Terminated7
Withdrawn4
Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
110
Active
3
Success Rate
91.7%
Most Advanced
Phase 4

Trials by Phase

Phase 113 (11.9%)
Phase 222 (20.2%)
Phase 332 (29.4%)
Phase 412 (11.0%)
N/A30 (27.5%)

Trials by Status

recruiting33%
completed7770%
not_yet_recruiting11%
withdrawn44%
terminated76%
unknown1816%

Recent Activity

Clinical Trials (110)

Showing 20 of 110 trialsScroll for more
NCT00862433Phase 1

Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

Completed
NCT07303803Phase 2

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Recruiting
NCT04801849Phase 2

Vitamin E Dosing Study

Completed
NCT02107976Not Applicable

Famine From Feast: Linking Vitamin C, Red Blood Cell Fragility, and Diabetes

Completed
NCT05616442Phase 4

Ketotifen in Non-Alcoholic Fatty Liver Disease Patients

Completed
NCT07331103Not Applicable

RESOLving INflammation Through Diet for Health (RESOLVIN)

Recruiting
NCT05771181Phase 2

Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

Recruiting
NCT06926712Phase 4

The Effect of Vitamin E Supplementation on Hospital Stay Duration in Non-cyanotic Heart Disease Children With Lower Respiratory Tract Infections

Not Yet Recruiting
NCT06509581Not Applicable

Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen

Completed
NCT06211478Phase 3

Role of Vitamin E in Gaucher Disease Patients

Completed
NCT04007874Phase 3

Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine

Unknown
NCT04502849

Apoptosis Proteins and Endothelial Dysfunction in Patients With Atherosclerosis of Peripheral Arteries

Completed
NCT06081257Not Applicable

The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve

Unknown
NCT03916068Phase 2

Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy

Terminated
NCT01508221Phase 2

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

Completed
NCT03669133Phase 2

Vitamin E for NASH Treatment in HIV Infected Individuals

Terminated
NCT04509583Not Applicable

The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation

Completed
NCT05906498Phase 3

Using Acetylcysteine and Vitamin E With Psoriasis Vulgaris

Unknown
NCT00054561Phase 3

Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Completed
NCT03903133Phase 4

Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients

Completed

Drug Details

Intervention Type
OTHER
Total Trials
110